Biotechnology News

April 24, 2012

SAN DIEGO--(BUSINESS WIRE)--Pathway Genomics Adds Prominent Bioinformatics Experts to Scientific Advisory Board

April 24, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Carolina Liquid Chemistries announces the market launch of the CLC 720, the most technologically advanced chemistry analyzer to hit the market since the 1990s.

April 24, 2012

SCHAUMBURG, Ill.--(BUSINESS WIRE)--The Gateway for Cancer Research supports Phase 1 clinical study at the MD Anderson Cancer Center to use a newly designed, nanotechnology-enhanced curcumin compound in cancer patients.

April 24, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Pharmaceutical brand teams are generally dissatisfied with their outsourced digital marketing, according to a study by Cutting Edge Information.

April 24, 2012

NEW ORLEANS, La.--(BUSINESS WIRE)--GE Healthcare today presented the results of a randomized study analyzing the effect of DaTscan™ (Ioflupane I 123 Injection) SPECT imaging in a group of adult patients with clinically uncertain parkinsonian...

April 24, 2012

TORONTO--(BUSINESS WIRE)--Venture Capital firm, Klass Capital, is pleased to announce a partnership with Healthcare of Ontario Pension Plan to significantly increase the size of Klass Capital Fund I, LP.

April 24, 2012

DENVER--(BUSINESS WIRE)--Colorado BioScience Association (CBSA) is now accepting applications from emerging bioscience companies for the Venture Showcase Competition at BioWest 2012.

April 24, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinipace Worldwide today announced Ran Frenkel, RPh, Vice President, International Business Development, was recently elected to the 2012-2013 IISRA Board of Directors.

April 24, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that it will report its first quarter 2012 financial results on Tuesday, May 8, 2012, after the close of financial markets. Following the announcement, company...

April 24, 2012

BOLOGNA, Italy--(BUSINESS WIRE)--Silicon Biosystems, S.p.A., a provider of specialized molecular and cellular biology technologies, will present at the Fourth World Circulating Tumour Cells Summit.

April 24, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it will report financial results for the first quarter of 2012 on...

April 24, 2012

MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--PhotoMedex, Inc. (NasdaqGS: PHMD) today announced the pricing of concurrent registered offerings of 3,023,432 shares of its common stock at a price to the public of $13.23 per share. The gross proceeds to...

April 24, 2012

SEATTLE--(BUSINESS WIRE)--Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, today announced that clinical and preclinical data will be presented during poster sessions at The...

April 24, 2012

CONCORD, Calif. & NEW YORK--(BUSINESS WIRE)--Cerus and New York Blood Center enter research collaboration to explore creation of red blood cell (RBC) biologic product with improved uniformity compared to a standard unit of red blood cells.

April 24, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics, announced today that a poster presentation on its lead drug candidate EBI-005...

April 24, 2012

CARLSBAD, Calif. & BOSTON--(BUSINESS WIRE)--BioPharm America™ 2012 capitalizes on thriving life science players in Boston

April 24, 2012

LAVAL, Quebec--(BUSINESS WIRE)--INCIVEK™ (telaprevir) Now Funded for People With Hepatitis C in Quebec and Saskatchewan

April 24, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--RedHill Biopharma announced the commencement of a pivotal bioequivalence clinical trial with RHB-103, an oral thin-film formulation of a leading triptan for the treatment of acute migraine.

April 24, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that research conducted by scientists at the University of Arkansas demonstrates the superior...

April 24, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research is pleased to announce Patricia Bland as executive director of corporate development.

April 24, 2012

BOULDER, Colo.--(BUSINESS WIRE)--miRagen Therapeutics announces addition of Dr. Arthur A. Levin to its Executive Team as EVP of R&D. Dr. Levin to help advance microRNA (miRNA)-based therapeutics pipeline into clinical development.

April 24, 2012

BOULDER, Colo.--(BUSINESS WIRE)--miRagen Therapeutics Secures $20 M Series B Financing. Funding to advance company's pipeline of compelling microRNA (miRNA)-based therapeutic candidates.

April 24, 2012

WESTON, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) announced that detailed positive data from CONFIRM, the second Phase 3 clinical trial of oral BG-12 (dimethyl fumarate) in people with relapsing-remitting multiple sclerosis (RRMS...

April 24, 2012

DUBLIN--(BUSINESS WIRE)--ICON (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter...

April 24, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics AB (Publ) (STO:PREC), Corporate Identity No. 556545-6596 Interim Report for the Period January – March 2012 The group’s net sales for the first quarter was SEK 4.7 million (3.6) The...

April 24, 2012

ST. LOUIS--(BUSINESS WIRE)--Partek Incorporated is debuting new enhancements and features to their next generation sequencing software, Partek® Flow®, at the Bio-IT World Expo and Conference in Boston, April 24-26.

April 24, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen reported the initial validation of two additional therapeutic product candidates, CGEN-15031 and CGEN-15051, in animal models of autoimmune diseases.

April 24, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--Torax Medical today announced Keck Medical Center of USC, Mayo Clinic Florida, and UC San Diego Health System of UCSD are among the first centers offering a new procedure using the LINX® Reflux Management System...

April 24, 2012

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--MicroDose Therapeutx, Inc. announced today that it has concluded the second of two Phase I studies with its novel inhaled antiviral fusion inhibitor, MDT-637, for the treatment of RSV infection.

April 24, 2012

PALO ALTO, Calif. & OSAKA, Japan--(BUSINESS WIRE)--Affymax, Inc. (NASDAQ:AFFY) and Takeda Pharmaceutical Company Limited (TSE:4502), today announced that OMONTYS® (peginesatide) Injection is now available only for use in treating anemia due...

April 24, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today reported business and financial highlights for the quarter...

April 24, 2012

WASHINGTON & PORTOLA VALLEY, Calif.--(BUSINESS WIRE)--Greenleaf Health LLC today announced that Linda Carter and Alice Jack – both experts within the field of FDA regulated medical products – have joined the firm.

April 24, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex to Present at the Deutsche Bank 37th Annual Health Care Conference

April 24, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial results for the three months ended March 31, 2012. The Company reported net product sales of Soliris® (eculizumab) of $244.7 million, an...

April 24, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica will be presenting at the JMP Securities Research Conference on May 14, 2012 in San Francisco. Mark Weinstein will update investors on the company's progress, and it will be webcast.

April 24, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals updates shareholders on its clinical and corporate progress for 2011 and early 2012, advancing its goal of regulatory approval for its novel oncological & derma therapies.

April 24, 2012

KANSAS CITY, Mo.--(BUSINESS WIRE)--Diatron Group (Diatron), a Swiss-based provider of hematology and clinical chemistry analyzers, has received FDA 510(k) premarket approval for its advanced laser optics hematology analyzer.

April 24, 2012

REDWOOD CITY, Calif. & DANVILLE, Va.--(BUSINESS WIRE)--Virdia today announced the opening of its demonstration facility at its new technology center in Danville, VA.

April 24, 2012

OXFORD, England--(BUSINESS WIRE)--PsiOxus Therapeutics has opened a new state of the art laboratory at Milton Park as part of its expansion plans. The facility has been designed and equipped as a category two laboratory for the handling of live...

April 24, 2012

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ: 4573) pleased to announce the completion of a phase I clinical study of RK-023, a new compound that is being developed for the treatment of hypotrichosis of the eyelashes.

April 24, 2012

GOETTINGEN, Germany--(BUSINESS WIRE)--Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment provider, started off fiscal 2012 with substantial gains in order intake, sales revenue and earnings. Based on the company'...

April 24, 2012

DUBAI--(BUSINESS WIRE)--World Heart Federation, World Congress of Cardiology Scientific Sessions 2012 - April 23, 2012 Seventy patient and professional organisations from 39 countries united in Dubai this week at the World Heart Federation’s...

April 24, 2012

BROOMFIELD, Colo.--(BUSINESS WIRE)--OEL Fastrac, a simple an affordable way to obtain occupational exposure limits for active pharmaceutical ingredients. Visit affygility.com for more information.

April 23, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) will webcast its annual meeting of shareholders on Tuesday, May 8, 2012, at 9:00 a.m. Central Time. This call is being webcast by Thomson Reuters and can be accessed along...

April 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the first quarter of 2012. First quarter 2012 results: Revenue of $273 million, a 3% decrease compared to $283 million in the first quarter of 2011...

April 23, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (Nasdaq:ARRY) will report financial results for the third quarter of fiscal 2012 on Monday, April 30, 2012, and will hold a conference call on Tuesday, May 1, 2012 at 9:00 a.m. Eastern time to...

April 23, 2012

GOLDEN, Colo.--(BUSINESS WIRE)--Luca Technologies Inc., a global market leader in biogenic methane gas creation and production, today announced that it has decided not to pursue its initial public offering due to adverse market conditions. The...

April 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that David Warshawsky, Ph.D., CEO of BioTime’s subsidiary LifeMap Sciences, Inc. will provide and update on product development at an investor meeting in New York...

April 23, 2012

NEW YORK--(BUSINESS WIRE)--Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors of Ardea Biosciences, Inc. (“Ardea” or the “Company”) (NASDAQ:RDEA) (ISIN: US03969P1075) concerning the proposed acquisition of...